$GTCH "Fundamentally, today’s advanced chips are having

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
162

$GTCH "Fundamentally, today’s advanced chips are having smaller devices with smaller geometries. The silicon areas become more compact and crowded which impacts performance, power consumption and reliability. GAA FET technology is expected to provide performance enhancement with lower power consumption, which we believe makes it attractive for design firms. Another important aspect is that GAA FET relaxes some of the problems introduced by the traditional FinFETS. The new transistor structure is designed to provide stronger device gate control which would enable better conductivity and improved electrical characteristics. This is an important factor because at the smaller nodes, we are noticing more variability, particularly for memories. But with new technologies, typically comes uncertainty. With GAA FET we can expect higher potential for variability and design rule challenges, especially with today’s billions of transistors and advanced functionalities ICs. The ever-going demand to consume minimal power and to operate with high performance using GAA FET, could become a major obstacle for design firms, delaying milestones and timelines. GBT plans to develop GAA FET support for all its EDA productivity enhancement software tools with the goal of saving significant design time, enabling IC designers to maintain competitive schedules. We are going to start with our interactive identification and correction of design rule violations program. This tool operates during the construction of an IC layout, providing an on-the-fly feedback about violations. The tool also offers automatic correction of the detected violation and could save major project’s design time. Without the appropriate level of geometrical accuracy within an affordable time frame designers might need many extra months to reach the desired signoff schedule. Design Rule identification and correction process is a critical step during signoff, and without an intelligent productivity technology an enormous amount of pressure is put on designers to achieve design closure in a timely manner. Supporting GAA FET technology will enable IC designers to achieve design closure in a timely manner, meeting or shortening desired schedules and time to market milestones” provided Danny Rittman, the Company’s CTO.

https://seekingalpha.com/pr/18746050-gbt-deve...oductivity
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 238

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 12

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 315

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 286

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 110

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 183

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Anytime Fitness Launches First Club in Dubai, UAE, Expanding Reach

Updated Category News Views 508

Anytime Fitness Sets Foot in Dubai with Grand Opening The new club in the Arjan district signifies a vital expansion of fitness services to the United Arab Emirates; members benefit from personalized wellness plans, state-of-the-art Technogym equipment, and SmartCoaching services available through the AF App. Purpose Brands LLC has announced the grand opening of its very...

Continue Reading
Crescent Biopharma's Strategic Partnership and Market Moves

Updated Category News Views 196

Crescent Biopharma's Recent Stock Activity Crescent Biopharma, Inc. (NASDAQ: CBIO) has been experiencing a notable fluctuation in its stock value lately. Shares initially showed a positive trend, indicating investor optimism following their recent announcement, but later reversed course and began to dip slightly. This change in trading comes as the company unveiled a...

Continue Reading
Investors Alert: Legal Developments for Snap Inc. Shareholders

Updated Category News Views 167

Important Update for Snap Inc. Shareholders If you have invested in Snap Inc. (NYSE: SNAP) and purchased shares in 2021 or earlier, there are significant legal developments that you should be aware of. A recent lawsuit is reportedly pending, and the Shareholders Foundation has urged impacted investors to take action. Details of the Lawsuit Against Snap Inc. The lawsuit...

Continue Reading
Understanding the Influence of Trump's Fiscal Policies on Debt

Updated Category News Views 493

Understanding the Influence of Trump's Fiscal Policies on Debt When it comes to government debt, being large isn't necessarily an advantage. Recent fiscal policies introduced by the Trump administration, including tariffs and the initiatives of the Department of Government Efficiency, aim to address the growing fiscal deficit. However, the overall effect may result in...

Continue Reading
Analyzing Sea's Short Interest Trends and Market Implications

Updated Category News Views 128

Understanding Sea's Short Interest Dynamics Sea's short percent of float has notably increased by 5.22% since the latest report. The company currently has 21.99 million shares sold short, which accounts for 7.46% of its total shares available for trading. Based on recent trading volumes, it would take an average of 5.24 days for traders to cover their short positions....

Continue Reading